Charles River Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.47B 138M 2025-01
Align Technology USD 873.01M 170.88M 2025-03
Bio-Rad Laboratories USD 521.4M 33.3M 2025-03
Bruker USD 183.4M 35.3M 2024-12
Cardinal Health USD 3.33B 484M 2025-03
Charles River Laboratories USD 194.61M 15.56M 2024-12
Cigna USD 8.33B 784M 2025-03
CVS Health USD 10.08B 1.49B 2025-03
Danaher USD 1.99B 85M 2025-03
Dentsply International USD 272M 24M 2024-12
Elevance Health USD 7.5B 788M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Hologic USD 1.43B 352.6M 2025-03
Humana USD 4.25B 2.03B 2025-03
Illumina USD 1.13B 258M 2024-12
Incyte USD 2.41B 720.83M 2025-03
IQVIA Holdings USD 1.7B 130M 2024-12
Laboratory Of America USD 369.4M 1.15B 2025-03
Lonza CHF 1.11B 286M 2024-12
McKesson USD 1.13B 1.38B 2024-12
Merck EUR 2.15B 1.01B 2024-12
Mettler Toledo International USD 64.29M 4.93M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.04B 49M 2024-12
Quest Diagnostics USD 188M 361M 2025-03
Revvity USD 1.14B 25.78M 2025-03
Thermo Fisher Scientific USD 4.13B 125M 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03
UnitedHealth USD 34.29B 8.98B 2025-03
Walgreens Boots Alliance USD 702M 157M 2025-02
Waters USD 324.42M 6.09M 2024-12
West Pharmaceutical Services USD 404.2M 80.4M 2025-03



Charles River Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.